Dihydroergocryptine
- Level
- Commodity
- Parent
- 51142500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51142522This classification denotes an antiparkinson drug with the molecular formula C32H43N5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 67V3FSL2GL, chemically known as ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, but generally known as Dihydroergocryptine, which bears US NIH Compound Identifier 114948. European Medicines Agency schedules Dihydroergocryptine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13588MIG. World Health Organization schedules amantadine in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, DIHYDROERGOCRYPTINE remains the US FDA Preferred Term for this commodity. SMILES: CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.
Same parent
Under 51142500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.